title: The first case of acute T-cell lymphoblastic leukemia containing the e19a2 BCR-ABL1 transcript: a durable molecular response using imatinib-based chemotherapy.
authors.affiliation: a Department of Hematology and Hematology Research Laboratory , West China Hospital, Sichuan University , Chengdu , P.R. China.
authors.forename: Wanhua
authors.initials: W
authors.lastname: Zhang
authors.affiliation: a Department of Hematology and Hematology Research Laboratory , West China Hospital, Sichuan University , Chengdu , P.R. China.
authors.forename: Yunfan
authors.initials: Y
authors.lastname: Yang
authors.affiliation: a Department of Hematology and Hematology Research Laboratory , West China Hospital, Sichuan University , Chengdu , P.R. China.
authors.forename: Liping
authors.initials: L
authors.lastname: Xie
authors.affiliation: b Department of Laboratory Medicine , West China Hospital, Sichuan University , Chengdu , P.R. China.
authors.forename: Yuanxin
authors.initials: Y
authors.lastname: Ye
authors.affiliation: a Department of Hematology and Hematology Research Laboratory , West China Hospital, Sichuan University , Chengdu , P.R. China.
authors.forename: Ting
authors.initials: T
authors.lastname: Liu
authors.affiliation: a Department of Hematology and Hematology Research Laboratory , West China Hospital, Sichuan University , Chengdu , P.R. China.
authors.forename: Yu
authors.initials: Y
authors.lastname: Wu
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015415:Biomarkers; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D056905:Chromosome Breakpoints; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use; D016130:Immunophenotyping; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012333:RNA, Messenger; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D047428:Protein Kinase Inhibitors; D012333:RNA, Messenger; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl